HARP Shares Outstanding History



Below is a table of the HARP shares outstanding history going back to 2/8/2019:

Date HARP Shares Outstanding
2/8/20192.39M
2/28/20192.43M
4/30/20192.44M
7/31/20192.46M
10/31/20192.46M
2/29/20202.49M
4/30/20202.50M
7/31/20202.51M
10/31/20202.54M
2/28/20213.24M
4/30/20213.25M
7/31/20213.27M
10/31/20213.27M
2/28/20223.30M
4/29/20223.31M
7/29/20223.31M
10/31/20223.32M
2/28/20233.74M
4/28/20233.76M
7/31/20233.88M
10/31/202316.93M

Also see: HARP Market Cap History
HARP YTD Return
HARP Historical Shares Outstanding:
+51.32% CAGR
HARP Historical Shares Outstanding: +51.32% CAGR

Mouse over chart for data details
2/8/2019 ...10/31/2023
Harpoon Therapeutics is a clinical-stage immunotherapy company. Co.'s Tri-specific T cell Activating Construct (TriTACs) product candidates include: HPN328, which is for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217, which is for the treatment of multiple myeloma; and HPN536, which is for the treatment of ovarian and pancreatic cancers and other mesothelin- expressing solid tumors. Co.'s proprietary TriTAC product candidate is HPN601, which targets the epithelial cell adhesion molecule and is being developed for the treatment of multiple solid tumor indications. We show 21 historical shares outstanding datapoints in our coverage of HARP's shares outstanding history.

Understanding the changing numbers of HARP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like HARP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching HARP by allowing them to research HARP shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree HARP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Harpoon Therapeutics (HARP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

HBIO Shares Outstanding History
HCA Shares Outstanding History
HCWB Shares Outstanding History
HEPA Shares Outstanding History
HGEN Shares Outstanding History
HILS Shares Outstanding History
HJLI Shares Outstanding History
HLTH Shares Outstanding History
HLVX Shares Outstanding History
HMSY Shares Outstanding History
More Healthcare companies »

 

HARP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.